SCHEMBL6573169

SCHEMBL6573169

CCS(=O)(=O)N(c1cc(F)c(F)cc1C#N)S(=O)(=O)CC

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.34
AR P10275 3/20 0.31
ALDH1A1 P00352 1/20 0.30
HTT P42858 1/20 0.30
KHK P50053 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6573160 0.83 TRPV4 (0.36) TRPV4ALDH1A1HTTKHK
SCHEMBL6174881 0.74 HTR1A (0.34)
SCHEMBL6715830 0.73
SCHEMBL21048806 0.72 ALDH1A1 (0.46) ALDH1A1HTT
SCHEMBL6719695 0.72 AR (0.31) AR
SCHEMBL6699227 0.72 BCAT2 (0.35)
SCHEMBL28745348 0.71 ALDH1A1 (0.38) ALDH1A1HTT
SCHEMBL7679161 0.71 KHK (0.35) TRPV4KHK
SCHEMBL22188019 0.69 TRPV4 (0.42) TRPV4ARKHK
Sulfuric Acid SCHEMBL28577786 0.68 TRPV4 (0.45) TRPV4ALDH1A1KHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003718-B1 METHOD FOR THE PRODUCTION OF N-(5-AMINO-2-CYANO-4-FLUORO-PHENYL)-SULPHONAMIDES BAYER CROPSCIENCE AG (DE) 2004-04-28 EP disclosed
US-6545154-B2 Herbicides BAYER AKTIENGESELLSCHAFT (DE) 2003-04-08 US disclosed
US-20030040626-A1 Method for the production of N-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides and new intermediate products HUPPERTS ACHIM (DE) 2003-02-27 US disclosed
US-6310206-B1 2-AMINO-4,5-DIFLUORO-BENZONITRILE IS REACTED A SULPHONYL HALIDES; N-(2-CYANO-4,5-DIFLUORO-PHENYL)-SULPHONAMIDES (CLAIMED AS INTERMEDIATES) OBTAINED IN THE FIRST STEP ARE AMINATED WITH AMMONIA BAYER AKTIENGESELLSCHAFT (DE) 2001-10-30 US disclosed
EP-1003718-A1 METHOD FOR THE PRODUCTION OF N-(5-AMINO-2-CYANO-4-FLUORO-PHENYL)-SULPHONAMIDES AND NEW INTERMEDIATE PRODUCTS BAYER AG (DE) 2000-05-31 EP disclosed
WO-1999005098-A1 METHOD FOR THE PRODUCTION OF N-(5-AMINO-2-CYANO-4-FLUORO-PHENYL)-SULPHONAMIDES AND NEW INTERMEDIATE PRODUCTS BAYER AKTIENGESELLSCHAFT (DE) 1999-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030040626-A1 Method for the production of N-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides and new intermediate products PFAS, SRM, NISCH TRPV4 939/4885AR 4357/4885ALDH1A1 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.